NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

MAVERICK CAPITAL LTD's Holding History (CIK: 0000934639)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 1,894,226 Value ($000) $66,449 Avg Close $36.39 Range $28.19 - $42.00

Q3 2025

Shares 1,504,747 Value ($000) $42,795 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 1,531,874 Value ($000) $27,742 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 549,469 Value ($000) $11,248 Avg Close $22.23 Range $17.18 - $26.80

Q4 2024

Shares 350,005 Value ($000) $8,995 Avg Close $21.24 Range $15.51 - $27.29

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	1,894,226	$66,449	$36.39	$28.19 - $42.00
Q3 2025	1,504,747	$42,795	$23.97	$17.97 - $28.91
Q2 2025	1,531,874	$27,742	$18.24	$14.06 - $22.25
Q1 2025	549,469	$11,248	$22.23	$17.18 - $26.80
Q4 2024	350,005	$8,995	$21.24	$15.51 - $27.29